Myriad Genetics | MYGN - Ebit


Myriad Genetics reported $-5.5M in EBIT for its fiscal quarter ending in March of 2025.





Ebit Change Date
Agilent USD 443M 66M Sep/2025
Becton, Dickinson and Co. USD 826M 153M Sep/2025
Bio-Rad Laboratories USD 426.6M 363.6M Jun/2025
Bruker USD 83.9M 72M Sep/2025
Danaher USD 1.5B 348M Dec/2025
Exact Sciences USD -25M 22.85M Sep/2025
Hologic USD 240.9M 12.1M Dec/2025
Illumina USD 250M 81M Sep/2025
J&J USD 5.11B 2.3B Dec/2025
Mettler Toledo International USD 294.2M 28.77M Sep/2025
Myriad Genetics USD -5.5M 11.1M Mar/2025
Quest Diagnostics USD 386M 52M Sep/2025
Quidel USD 45.2M 47M Sep/2025
Repligen USD 16.81M 10.85M Sep/2025
Revvity USD 98.34M 7.58M Sep/2025
Standard Biotools USD -32.89M 14.62M Sep/2025
Thermo Fisher Scientific USD 2.3B 226M Dec/2025
Veracyte USD 23.11M 8.8M Sep/2025
Waters USD 192.11M 3.9M Sep/2025